TSYNTH
Live / Registered — Registered (as of 05 Aug 2025)
What this means for you
Registered since 05 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98270164
- Registration number
- 7883825
- Mark type
- Stylized text
- Filed
- 14 Nov 2023
- Published for opposition
- 29 Oct 2024
- Registered
- 05 Aug 2025
- Attorney of record
- Calvin Chai
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for medical or veterinary purposes; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Genetic identity tests comprised of reagents for medical purposes; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Preparations for detecting mutation in prion genes for medical purposes; Protein arrays for medical diagnosis purposes
Owner
- Beijing Tsingke Biotech Co.,Ltd., Beijing, CN
- Beijing Tsingke Biotech Co.,Ltd., Beijing, CN
- Beijing Tsingke Biotech Co.,Ltd., Beijing, CN
Prosecution history
- 05 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 15 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jul 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Jul 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Jul 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Jul 2025 — ASSIGNED TO LIE
- 29 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Apr 2025 — NON-FINAL ACTION E-MAILED
- 09 Apr 2025 — SU - NON-FINAL ACTION - WRITTEN
- 19 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Jan 2025 — USE AMENDMENT FILED